Here, the three novel NRAS mutations—c.142G>T (G48C), c.127C>A (Q43K), and c.109G>A (E37K)—were characterized for their effects on cancer phenotypes in vitro, using NIH3T3 and HCT116 cells. Here, NRAS is linked to cancer.